Angiotensin receptor blockade and portal hypertension: paradise gained and paradise lost

Review

A J Sanyal. Gastroenterology. 2001 Aug.

. 2001 Aug;121(2):487-90.

doi: 10.1053/gast.2001.26770.

No abstract available

Comment on

Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.
González-Abraldes J, Albillos A, Bañares R, Del Arbol LR, Moitinho E, Rodríguez C, González M, Escorsell A, García-Pagán JC, Bosch J. González-Abraldes J, et al. Gastroenterology. 2001 Aug;121(2):382-8. doi: 10.1053/gast.2001.26288. Gastroenterology. 2001. PMID: 11487547 Clinical Trial.
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.
Schepke M, Werner E, Biecker E, Schiedermaier P, Heller J, Neef M, Stoffel-Wagner B, Hofer U, Caselmann WH, Sauerbruch T. Schepke M, et al. Gastroenterology. 2001 Aug;121(2):389-95. doi: 10.1053/gast.2001.26295. Gastroenterology. 2001. PMID: 11487548 Clinical Trial.